Epigral Ltd
company logo

Epigral Ltd

Chemicals
Mid Cap

-

0 (0%)


Epigral Ltd Performance

-

-

-

-


-

-

-

-

-

Epigral Ltd Fundamentals

7,031.53Cr

28.10

5.61

0.67

60.22

0.30%

301.83

i buttonClick here to know more about Fundamentals

Epigral Ltd Financials

Epigral Ltd Financialsright-arrow

Epigral Ltd Shareholding Pattern

Epigral Ltd Delivery and Volume

About Epigral Ltd

Meghmani Finechem Limited was incorporated in 2007 as a subsidiary of Meghmani organics ltd, under the provisions of Companies Act, 1956. The Company at present is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical

Maulik Jayantibhai Patel

2007

EPIGRAL

NameDesignation
Maulik Jayantibhai PatelChairman & Managing Director
Kaushal Ashishbhai SoparkarExecutive Director
Karana Rameshbhai PatelNon Executive Director
Ankit Natwarlal PatelNon Executive Director
Darshan Anandbhai PatelNon Executive Director
Manubhai Khodidas PatelIndependent Director
NIRALI BHAVIN PARIKHIndependent Director
Sanjay K AsherIndependent Director
Kanubhai S PatelIndependent Director
Raju SwamyIndependent Director
Gaurang Trivedi.Company Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

Epigral Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Epigral Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Epigral Ltd's share price is ₹1687.35 as of 2024-07-26.
Epigral Ltd's P/E ratio is 28.1 times as of 2024-07-26.
Epigral Ltd's most recent financial reports indicate a price-to-book ratio of 5.61, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Epigral Ltd's market capitalization is ₹7031.53 Cr as on 2024-07-26.
The current financial records of Epigral Ltd show a 16.85% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Epigral Ltd's most recent financial filings, the company has a total asset value of ₹501.93, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Epigral Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Epigral Ltd's 52-week high and low as of 2024-07-26 are ₹1763.35 and ₹1676.7, respectively.